COMPANY
Neurelis
FDA-approved therapeutic company
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Territory Manager | Inland Empire, CA | Inland Empire, CA, Remote | Sep 18, 2026 | Oct 16, 2026 |
| Senior Analyst, Commercial Operations | Neurelis- HQ | Sep 11, 2026 | Oct 16, 2026 |
| Senior Manager, Access Marketing | Neurelis HQ (San Diego) Or Remote | Aug 31, 2026 | Oct 16, 2026 |
| Senior Manager, Digital Marketing | Neurelis HQ (San Diego) Or Remote | Aug 31, 2026 | Oct 16, 2026 |
| Medical Science Liaison / Sr Medical Science Liaison | Northeast Region | Northeast Region, Remote | Aug 31, 2026 | Oct 16, 2026 |
Timeline
- FDA FDA New indication / efficacy supplement: VALTOCO (diazepam) — NDA211635/10, Apr 15, 2025. Applicant at approval: Neurelis, Inc. source ↗
FDA records (last 2 years)
- FDA New indication / efficacy supplement: VALTOCO (diazepam) — NDA211635/10, Apr 15, 2025. Applicant at approval: Neurelis, Inc. source ↗
Raises and investors new
- InvestorListed in the portfolio of OrbiMed (captured Oct 12, 2026). portfolio page ↗
Open jobs 5
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Territory Manager | Inland Empire, CA | Inland Empire, CA, Remote | Sep 18, 2026 | Oct 16, 2026 | Not stated |
| Senior Analyst, Commercial Operations | Neurelis- HQ | Sep 11, 2026 | Oct 16, 2026 | Senior |
| Senior Manager, Access Marketing | Neurelis HQ (San Diego) Or Remote | Aug 31, 2026 | Oct 16, 2026 | Senior |
| Senior Manager, Digital Marketing | Neurelis HQ (San Diego) Or Remote | Aug 31, 2026 | Oct 16, 2026 | Senior |
| Medical Science Liaison / Sr Medical Science Liaison | Northeast Region | Northeast Region, Remote | Aug 31, 2026 | Oct 16, 2026 | Not stated |
Connect
See your connections at Neurelis on LinkedIn (search by name, results not checked)